The American Chamber of Commerce in Japan
  • The ACCJ
    • About the ACCJ
    • ACCJ News
    • The Journal
    • Committees >
      • Committee List
      • Leadership Guide >
        • Leadership Guide Contents
        • Advocacy
        • Communications
        • Programs
        • Committee Excellence Advisory Council
    • Leadership
    • Press Releases
    • Community Service
    • Business & Service Directory
    • Promotional & Sponsorship Opportunities
    • Testimonials
    • Frequently Asked Questions
    • Careers >
      • External Affairs Director
      • ACCJ Internships
      • ACCJ Internship Portal
  • COVID-19 BCN
    • Business Continuity Network
    • BCN Events
    • BCN Library
    • COVID-19 Webinar Summaries & Videos >
      • BCN Moderate
    • ACCJ vs COVID-19
    • BCN COVID-19 Surveys
  • Chapters
    • ACCJ Tokyo Chapter
    • ACCJ Kansai Chapter
    • ACCJ Chubu Chapter
  • Membership
    • Become a Member
    • Commercial Membership Directory
    • Corporate Sustaining Members
    • Policies and Guidelines >
      • Respecting Member Privacy
      • Privacy Policy
      • Social Media Guidelines
      • Guidance for Appropriate Conduct
  • Join Us
  • Events
    • ACCJ Events
    • Events
    • Signature Events >
      • Charity Ball
      • Mercedes-Benz - Cole Haan Cup
      • Walk-a-Thon
      • Women in Business Summit
    • Community Events
  • Advocacy
    • Advocacy Overview
    • White Papers
    • Viewpoints
    • Public Comments
    • Other Documents
  • Contact
  • Log in

9/20/2018

Value-focused Model-informed Drug Discovery and Development (MID3) Strategies Key to Future Health Policy

Read Now
 
Picture
Date: Thursday, September 20, 2018
Time: 12:00 - 14:00
Venue: Tokyo American Club, 
Brooklyn Room

Speaker: Dr. Leigh Farrell, Senior Vice President Commercial, Certara
Hosting Committees: 
Healthcare, 
​Medical Devices and Diagnostics, 
Pharmaceuticals, 
Regenerative Medicine and Bioscience
Member Fee: 4,500
Guest Fee: 7,900
Meal: Plated Lunch 
Registration/Cancellation Deadline: Friday, September 14, 12:00 noon​
SIGN UP
Model-informed Drug Discovery and Development (MID3) integrates computational modeling and simulation with drug development expertise and real-world data. Dr. Farrell will present how MID3 is being applied at every stage of drug development from preclinical and clinical research through to market access strategy and post-marketing activities.

He will show how MID3 increases certainty at every step from identifying the best new drug candidate through to negotiating its value with payers and health authorities and how it provides quantitative assessments for key go/no-go decisions and informs comparative effectiveness, an important metric in value-based pricing.

MID3 is already accepted by all major health authorities, including Japan’s Pharmaceuticals and Medical Devices Agency (PMDA), the US Food and Drug Administration (FDA), Australian Therapeutic Goods Administration, European Medicines Agency, and China National Drug Administration. Indeed, in the past three years MID3 data has been used in 90% of all novel drugs approved by the US FDA. This innovative approach has stimulated new regulatory precedents and policies worldwide. MID3 is also being used to provide a quantitative framework to develop and deploy cost-effective drugs at the optimal dose to targeted patient populations. 

The adoption of MID3 methodologies: 

-Enable precision drug development and dosing to treat Japan’s ageing population
-Allow the creation of novel frameworks for delivering cost-effective healthcare and enable it to take a global leadership role in managing ageing populations
-Optimize planning and deployment of medical countermeasures (MCM) to treat infectious diseases and pandemic planning and readiness 
-Inform new regulatory science pathways for developing drugs for special populations, including elderly and pediatric patients and those with chronic or rare diseases. 

Dr. Farrell will show how MID3 is a game changer and a leading-edge development combining the power of modeling, simulation and data analytics. 

If you are in the healthcare industry, this is one event you will not want to miss.

ACCJ Healthcare Committee
ACCJ Digital Health Subcommittee 
ACCJ Medical Devices and Diagnostics Subcommittee
ACCJ Pharmaceuticals Subcommittee
ACCJ Regenerative Medicine and Bioscience Subcommittee

NOTE 1: This event is ON THE RECORD.

NOTE 2: If you cancel after the stated deadline, the full meeting fee will be charged to your account. All guests must be accompanied by an ACCJ member. Sorry, no substitutions or walk-ins.

NOTE 3: If you are driving to Tokyo American Club, please inform the ACCJ of the make, model, color and plate of the vehicle, by the registration deadline, as arrangements must be made. A 1,700 yen parking fee will apply.

Share


Comments are closed.
Details
    If you need to cancel your registration due to illness, travel to affected areas within the past 14 days, or contact with someone who has traveled to affected areas, and the cancellation deadline has passed, please contact programs@accj.or.jp and accommodations will be made through March. For more details, please click here. 
    ALL EVENTS

    Events by Month

    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    September 2019
    August 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016

    ​Location
    All 
    Chubu 
    Kansai 
    Tokyo
    ​

    Notes

    ACCJ events are for ACCJ members and their guests only. To learn more about becoming an ACCJ member, see the Membership section of this site or contact the Membership Services Department at: info@accj.or.jp 
    ​or (03) 3433-7304


    Event registrations and cancellations cannot be accepted by phone. Please access the ACCJ Member Data Center to register for events or to cancel your registration.

    Note to Corporate 
    Sustaining Members and Company Members:
     
    ​To redeem new member benefits such as free events or delegate attendance, please email the Membership Services Department at: 
    membership@accj.or.jp 
Proudly powered by Weebly
  • The ACCJ
    • About the ACCJ
    • ACCJ News
    • The Journal
    • Committees >
      • Committee List
      • Leadership Guide >
        • Leadership Guide Contents
        • Advocacy
        • Communications
        • Programs
        • Committee Excellence Advisory Council
    • Leadership
    • Press Releases
    • Community Service
    • Business & Service Directory
    • Promotional & Sponsorship Opportunities
    • Testimonials
    • Frequently Asked Questions
    • Careers >
      • External Affairs Director
      • ACCJ Internships
      • ACCJ Internship Portal
  • COVID-19 BCN
    • Business Continuity Network
    • BCN Events
    • BCN Library
    • COVID-19 Webinar Summaries & Videos >
      • BCN Moderate
    • ACCJ vs COVID-19
    • BCN COVID-19 Surveys
  • Chapters
    • ACCJ Tokyo Chapter
    • ACCJ Kansai Chapter
    • ACCJ Chubu Chapter
  • Membership
    • Become a Member
    • Commercial Membership Directory
    • Corporate Sustaining Members
    • Policies and Guidelines >
      • Respecting Member Privacy
      • Privacy Policy
      • Social Media Guidelines
      • Guidance for Appropriate Conduct
  • Join Us
  • Events
    • ACCJ Events
    • Events
    • Signature Events >
      • Charity Ball
      • Mercedes-Benz - Cole Haan Cup
      • Walk-a-Thon
      • Women in Business Summit
    • Community Events
  • Advocacy
    • Advocacy Overview
    • White Papers
    • Viewpoints
    • Public Comments
    • Other Documents
  • Contact
  • Log in